RCIPS current news
Lumkani, a University of Cape Town (UCT) spin-off company, with the mission to mitigate the loss of life and property caused by shack fires in South Africa and across the world, has won R20-million the EU’s EIC Horizon Prize.
Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT), the Center for Global Infectious Disease Research – Seattle in the United States, and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to serve multiple functions in the fight against TB.
Here’s a different reason for tobacco to be in the news. Cape Bio Pharms, a biotech company with its origins in the Biopharming Research Unit (BRU) at the University of Cape Town (UCT), has joined the global effort to create a fast and affordable antibody test for COVID-19, using a relative of the tobacco plant.
UCT alumni have designed a rig to increase production of the bottle spacers that administer metred medication dosages to patients
As COVID-19 infection and morbidity rates increase around the globe, a number of companies and academic institutions have entered the race to develop a vaccine to protect us from the lethal virus. Creating a vaccine is, however, a complex process and could take several months, if not years.
The South African national shutdown commenced on 27 March 2020 and will continue for 21 days. During this period RC&I staff will be working remotely and essentially all functions will be operating as normal.
The SA SME Fund recently launched the University Technology Fund (UTF), a first of its kind in Africa. The University of Cape Town (UCT) and Stellenbosch University are the first two universities that will participate in the fund, which will provide UCT spin-off companies with access to R50 million, as well as additional seed funding to support innovation projects within the university.
UCT launched the Innovation Builder Fund (IBF) in 2019 with the inaugural call for applications in the second semester. The IBF aims to fund projects to further develop and test preliminary research outputs from UCT where initial proof of concept has been demonstrated using research funding with the goal of increase the commercialisation of UCT technologies, or to better position them for next-round innovation funding. Funding of up to R500 000 per project is considered.
The UCT Laboratory Notebooks are in stock again and piled high behind Yandi Sopete and Taliep Hattas who will be handing the orders. RC&I prints the books for use by our research community. These books are compliant with the requirements for proof of inventorship and intellectual property rights, have numbered pages and space for sign-off and witnessing, in line with the requirements of international Good Laboratory Practice (GLP).
The focus on embracing appropriate health technology innovations has not been receiving enough attention. Most of the value propositions in health techs revolve around making healthcare affordable. However, by making technology low-cost does not automatically make if more affordable. There is a lot of innovation locked within such technology designs, however, the complexities of the healthcare industry are not considered.
Düsseldorf, Germany, November 18th, 2019. Nisonic AS, a startup co-founded by SINTEF and Cofounder in Norway, aims to make intracranial pressure (ICP) assessment as simple and easy as measuring body temperature. Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient’s ICP.